Company profile

Geneseeq Technology Inc.

Geneseeq Technology Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on August 29, 2025 and the most recent on August 29, 2025 (GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)). Its most common review panel is Pathology (1 device).

1AI devices

2025First decision

2025Latest decision

1Specialties

Timeline

August 29, 2025 · 510(k) K250003GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) · Pathology · PZM